ndd Medical Technologies, a developer of diagnostics for COPD, is turning its attention to COVID-19. The Andover, MA-based company is introducing single patient use, inline filters for its lung function testing devices in response to the virus.
The firm said the filters complement its portable EasyOne spirometry range, including EasyOne Air, Pro, and Pro LAB. ndd said its spirometers are of the most sensitive devices available, delivering reliable, real-time lung function results and enabling specialists diagnoses of chronic lung diseases, even at point-of-care.
ndd said the EasyOne range already delivers infection control with easy-to-wipe surfaces and single-use parts—everything that contacts with breath is replaced after use. ndd’s patented TrueFlow ultrasound technology translates airflow into ultrasound signals measured by sensors free from contact with breath, also enabling calibration-free accuracy for flow and volume measurements.
In a release, Dr. Trishul Siddharthan, Assistant Professor of Pulmonary and Critical Care Medicine at Johns Hopkins University, said, “There is a lot of research underway to investigate the long-term effects of COVID-19. Our research group has been partnering with ndd thanks to the reliability of these spirometers in global settings and the ease of cleaning these devices during the pandemic to ensure safety.”